Kanghong Investigative Site — Dallas, Texas

Kanghong Investigative Site is a clinical research site located in Dallas, Texas, United States 75231.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Kanghong Investigative Site has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Neovascular Age-related Macular Degeneration, Age-Related Macular Degeneration.

Sponsors: Chengdu Kanghong Biotech Co., Ltd., Chengdu Origen Biotechnology Co., Ltd..

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kanghong Investigative Site?

Kanghong Investigative Site has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kanghong Investigative Site conducted?

Kanghong Investigative Site has 2 clinical trials on record, with 1 currently active. Their work covers Neovascular Age-related Macular Degeneration, Age-Related Macular Degeneration.

Is Kanghong Investigative Site accredited by Crixeo Health?

Kanghong Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kanghong Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.